Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
InventisBio Co. Ltd. A
688382Current price
11.66 CNY
+0.08 CNY (+0.69%)
Last closed
11.54 CNY
Company
www.inventisbio.com
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
Shanghai Stock Exchange
Capitalization
6 052 566 300 CNY
Yield for 12 month
-33.56 %
1Y
3Y
5Y
10Y
15Y
688382
InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. The company's drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; D-0502, which is in Phase I clinical trial for the breast cancer indications; and D-1553, which in Phase I clinical trial for NSCLS, colorectal cancer indications. Its drug candidates for the metabolic therapeutic area is D-0120, a Phase I and II clinical trial product for hyperuricemia and gout indications. The company has a collaboration agreement with Betta Pharmaceuticals. InventisBio Co., Limited was founded in 2013 and is headquartered in Pudong, China. Address: No.4, Libing Road, Pudong, China, 201203
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
113.5 CNYP/E ratio
–Dividend Yield
–Current Year
+186 671 580 CNY
Last Year
–
Current Quarter
+6 305 837 CNY
Last Quarter
+8 659 145 CNY
Current Year
+186 671 580 CNY
Last Year
–
Current Quarter
+4 019 155 CNY
Last Quarter
+4 589 578 CNY
Key Figures 688382
1 year
3 years
5 years
10 years
EBITDA
-368 932 104 CNY
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-11.13 %
PEG Ratio
–
Return On Equity TTM
-16.96 %
Wall Street Target Price
113.5 CNY
Revenue TTM
121 142 955 CNY
Book Value
3.5 CNY
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-92.2 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-0.57 CNY
Diluted Eps TTM
-0.57 CNY
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-274.45 %
Dividend Analytics 688382
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 688382
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 688382
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
35.5839
Price Sales TTM
52.6926
Enterprise Value EBITDA
-12.1104
Price Book MRQ
3.3083
Financials 688382
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 688382
For 52 weeks
6.54 CNY
18.26 CNY
50 Day MA
8.6 CNY
Shares Short Prior Month
–
200 Day MA
9.44 CNY
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart